To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence and Evaluating Prognosis of Epithelial Ovarian Cancer
Conditions: Epithelial Ovarian Cancer; Stage III Ovarian Cancer; Stage IV Ovarian Cancer Sponsors: The First Hospital of Jilin University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Hospitals | Ovarian Cancer | Ovaries | Research